List of insiders holdings for SOLENO THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Vivo Ventures Fund V L.P. CHA ALBERT ENGLEMAN EDGAR 10% Owner | 2014-11-20 21:10:37 | 3,154,158 4,317,982 | 7,472,140 | Form 4 |
| 2 | Forward V Associates LLC FORWARD VENTURES V LP 10% Owner | 2017-03-13 19:17:49 | 0 7,251,728 | 7,251,728 | Form 4 |
| 3 | Vivo Ventures Fund V L.P. Vivo Ventures V Affiliates Fund L.P. Vivo Ventures V LLC BDF IV Annex Fund LP BIOTECHNOLOGY DEVELOPMENT FUND IV LP Biotechnology Development Fund IV Affiliates LP BIOASIA INVESTMENTS IV LLC BIOTECHNOLOGY DEVELOPMENT FUND II LP BIOASIA MANGEMENT LLC KUNG FRANK 10% Owner | 2019-11-04 17:31:04 | 4,952,195 0 | 4,952,195 | Form 13D |
| 4 | BIOASIA MANGEMENT LLC BIOASIA INVESTMENTS IV LLC 10% Owner | 2019-11-04 17:31:04 | 4,952,195 0 | 4,952,195 | Form 13D |
| 5 | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. 10% Owner | 2025-03-31 20:00:57 | 4,458,294 0 | 4,458,294 | Form 13G |
| 6 | ENGLEMAN EDGAR Director 10% Owner | 2018-02-07 20:10:21 | 0 4,027,292 | 4,027,292 | Form 4 |
| 7 | FEINBERG LARRY N ORACLE PARTNERS LP * See Remarks | 2021-02-16 16:02:48 | 3,732,640 0 | 3,732,640 | Form 13G |
| 8 | FEINBERG LARRY N ORACLE PARTNERS LP Oracle Associates LLC ORACLE INVESTMENT MANAGEMENT INC 10% Owner | 2021-02-16 16:02:48 | 3,732,640 0 | 3,732,640 | Form 13G |
| 9 | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner | 2024-10-21 16:31:27 | 2,003,101 0 | 2,003,101 | Form 13D |
| 10 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 2024-11-19 21:44:27 | 1,770,792 0 | 1,770,792 | Form 13D |
| 11 | Anish Bhatnagar CHIEF EXECUTIVE OFFICER | 2025-03-31 19:00:18 | 874,071 0 | 874,071 | Form 4 |
| 12 | Vivo Ventures V LLC Vivo Ventures Fund V L.P. Vivo Ventures V Affiliates Fund L.P. 10% Owner | 2020-06-11 17:00:29 | 836,137 0 | 836,137 | Form 13D |
| 13 | SCHULER JACK W 10% Owner | 2023-05-26 13:14:31 | 421,976 0 | 421,976 | Form 13D |
| 14 | O'Toole David D Director | 2017-04-24 06:17:25 | 354,945 0 | 354,945 | Form 4 |
| 15 | MARIO ERNEST Director | 2024-06-10 20:49:06 | 193,066 21,789 | 214,855 | Form 4 |
| 16 | Teknoinvest VIII KS Teknoinvest VIII B (GP) AS Teknoinvest VIII GP KS 10% Owner | 2014-11-12 21:57:45 | 110,982 91,904 | 202,886 | Form 3 |
| 17 | Mackaness James H CHIEF FINANCIAL OFFICER | 2025-03-31 19:20:00 | 190,427 0 | 190,427 | Form 4 |
| 18 | Huang Michael F. Sr. VP of Clinical Development | 2025-03-31 19:18:50 | 146,817 0 | 146,817 | Form 4 |
| 19 | Urbanski Raymond W. CHIEF DEVELOPMENT OFFICER | 2024-08-23 19:16:04 | 145,000 0 | 145,000 | Form 4 |
| 20 | Manning Meredith Chief Commercial Officer | 2025-03-31 19:21:03 | 136,351 0 | 136,351 | Form 4 |
| 21 | Yen Kristen SEE REMARKS | 2025-03-31 19:23:00 | 97,647 0 | 97,647 | Form 4 |
| 22 | Ebbers Ed See Remarks | 2015-05-28 17:53:03 | 75,000 0 | 75,000 | Form 3 |
| 23 | Nabhan Antoun See Remarks | 2014-11-14 14:39:16 | 64,886 0 | 64,886 | Form 4 |
| 24 | Wondka Anthony See Remarks | 2016-06-10 19:57:53 | 46,863 0 | 46,863 | Form 4 |
| 25 | ENGELSEN STEINAR J Director | 2018-02-07 19:38:37 | 41,831 0 | 41,831 | Form 4 |
| 26 | TP MANAGEMENT VII LLC TECHNOLOGY PARTNERS FUND VII LP TECHNOLOGY PARTNERS AFFILIATES VII LP 10% Owner | 2019-04-08 20:49:56 | 25,478 0 | 25,478 | Form 13G |
| 27 | Harris William G Director | 2025-06-09 19:20:06 | 19,392 0 | 19,392 | Form 4 |
| 28 | Volck Birgitte Director | 2025-06-09 19:27:59 | 17,536 0 | 17,536 | Form 4 |
| 29 | Bir Dawn Carter Director | 2025-06-09 19:19:03 | 16,991 0 | 16,991 | Form 4 |
| 30 | Glasheen James Walter Director | 2018-06-18 18:18:25 | 15,931 0 | 15,931 | Form 4 |
| 31 | DALAL RAJEN Director | 2018-06-18 18:17:27 | 15,931 0 | 15,931 | Form 4 |
| 32 | SHAH MAHENDRA Director | 2018-06-18 18:14:27 | 15,931 0 | 15,931 | Form 4 |
| 33 | Kirnon Stephen Director | 2018-02-07 19:54:31 | 14,996 0 | 14,996 | Form 4 |
| 34 | Hirano Patricia C SEE REMARKS | 2025-07-03 16:41:13 | 13,206 0 | 13,206 | Form 4 |
| 35 | Melincoff Gwen A Director | 2023-05-26 18:30:12 | 12,666 0 | 12,666 | Form 4 |
| 36 | Pauls Matthew Director | 2025-06-09 19:21:26 | 10,491 0 | 10,491 | Form 4 |
| 37 | Sinclair Andrew Director | 2025-06-09 19:25:16 | 10,491 0 | 10,491 | Form 4 |
| 38 | Wolter Jonathan Chief Financial Officer | 2019-01-28 20:11:34 | 10,000 0 | 10,000 | Form 4 |
| 39 | Phelps Gina Vice President of Sales | 2015-01-13 20:52:02 | 8,111 0 | 8,111 | Form 4 |
| 40 | COLLINSON STUART J Director | 2020-08-03 17:35:46 | 1,018 0 | 1,018 | Form 4 |
| 41 | ALEXANDER W JAMES Director | 2016-04-19 19:43:07 | 0 0 | 0 | Form 4 |